HAMILTON, ON, February 7, 2020 / – Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, today announced that it has signed contracts with seven new clients in Texas.

“We are pleased to announce that we continue to build on our customer traction in Texas,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc.  “We will be onboarding these seven new clients in Dallas, Laredo and Hidalgo County this month.  With these clients we are expanding into two new clinical use cases – Pediatric Remote Patient Monitoring (Pediatric RPM) and Principal Care Management (PCM).  Effective January 1, 2020, the Centres for Medicare & Medicaid Services (CMS) introduced PCM billing codes to allow specialists to use the iUGO Care platform to provide disease-specific care management to their patients.  Unlike the Chronic Care Management (CCM) billing codes, which are intended for use by a patient’s primary care provider and require that a patient have two or more chronic conditions, PCM provides reimbursement to specialists managing patients with one chronic condition.  This allows Endocrinologists, Nephrologists, Respirologists, Cardiologists and other specialists to provide ongoing care to their patients in the community setting to prevent complications, reduce the cost of care and improve health outcomes.”

Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market.  Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare.  iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery.  iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits.  Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.


“Dr. Lisa Crossley”

CEO and Director

For further information please contact:

Investor Relations at ir@reliqhealth.com


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws.  All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.

We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management. 

Reliq Health Technologies Inc. (the “Company“) does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.